CROI 2017 Program and Information

Program and Agenda

M. MALIGNANCIES P-M1 ANAL CANCER: SCREENING AND HPV (Tuesday)

P-M2 AIDS-RELATED CANCER: ART, RISK, INCIDENCE, AND BURDEN (Wednesday) P-M3 AIDS-RELATED CANCER: LYMPHOMA, KAPOSI SARCOMA, LUNG, AND LIVER (Thursday) N. CARDIOVASCULAR COMPLICATIONS OF HIV INFECTION AND ANTIRETROVIRAL THERAPY P-N1 CARDIOVASCULAR RISK AND ART EFFECTS (Wednesday) P-N2 DYSLIPIDEMIA AND HDL FUNCTION (Wednesday) P-N3 INTERVENTIONS TO PREVENT AND TREAT CARDIOVASCULAR DISEASE (Wednesday) P-N4 VASCULAR, CARDIAC, AND PULMONARY EVENTS (Wednesday) P-N5 INFLAMMATION, BIOMARKERS, AND RISK FACTORS FOR VASCULAR DISEASE (Tuesday) P-N6 INTEGRATION OF SCREENING AND TREATMENT OF NCD INTO HIV CARE IN RESOURCE-LIMITED SETTINGS (Tuesday) O. OTHER COMPLICATIONS OF HIV INFECTION AND ANTIRETROVIRAL THERAPY P-O1 IMMUNOLOGIC PREDICTORS OF MORBIDITY AND MORTALITY (Tuesday) P-O2 ART TOXICITY (Tuesday) P-O3 PULMONARY COMPLICATIONS (Wednesday) P-O4 FRAILTY AND MULTIMORBIDITY (Wednesday) P-O5 PREDICTORS OF INFLAMMATION ON ART (Thursday) P-O6 BONE DISEASE: RISK PREDICTION (Thursday) P-O7 BONE DISEASE: MECHANISMS (Thursday) P-O8 BONE DISEASE: INTERVENTIONS (Thursday) P-O9 RENAL DISEASE (Thursday) P-O10 ORGAN TRANSPLANTATION (Thursday) P-O11 METABOLIC COMPLICATIONS (Thursday) P-O12 OBESITY AND FATTY LIVER DISEASE (Thursday) P. TUBERCULOSIS AND OTHER OPPORTUNISTIC INFECTIONS P-P1 TB PREVENTION (Tuesday) P-P2 TB PATHOGENESIS AND DIAGNOSIS (Tuesday) P-P3 TB TREATMENT, OUTCOMES, AND MORTALITY (Tuesday) P-P4 TB EPIDEMIOLOGY AND BURDEN OF DISEASE (Wednesday) P-P5 TB AND CONTINUUM OF CARE (Wednesday) P-P6 TB AND OI IRIS (Wednesday) P-P7 TB COMORBIDITIES (Wednesday) P-P8 OI EPIDEMIOLOGY AND PATHOGENESIS (Thursday) P-P9 CRYPTOCOCCAL MENINGITIS AND OTHER FUNGAL OIs (Thursday) P-P10 NEUROSYPHILIS (Thursday) P-P11 PROTOZOAL OIs (Thursday) Q. MATERNAL/FETAL HIV P-Q1 PK AND SAFETY OF ARVs AND MONOCLONAL ANTIBODIES FOR PMTCT (Thursday) P-Q2 THE PMTCT CASCADE: TRANSMISSION, TESTING, AND VIRAL SUPPRESSION (Tuesday)

Poster Sessions P-Q3 PREGNANCY AND PREGNANCY OUTCOMES (Thursday) P-Q4 OUTCOMES OF HIV AND ARV-EXPOSED INFANTS (Tuesday) P-Q5 HIV DIAGNOSIS IN NEWBORNS AND INFANTS (Wednesday)

CROI 2017 214